TransThera Sciences (Nanjing). Inc. · FWB:J8J

TransThera Sciences (Nanjing). Inc. financial statements

TransThera Sciences (Nanjing). Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2020FY2019
Revenue001.18M124.0K61.8M
Cost of revenue0003.40M
Gross profit001.18M124.0K-3.40M
Research and development246.8M244.0M379.0K297.3K76.5M72.2M
Selling, general and administrative54.8M47.7M43.0K56.3K
Operating income-300.2M-286.7M-390.5M-312.3M-43.9M-98.4M
Depreciation and amortization5.03M6.44M7.40M8.91M4.59M3.40M
EBITDA-295.2M-280.2M-383.1M-303.4M-39.3M-95.0M
Interest expense121.0K201.0K248.5K184.9K37.8M16.4M
Income before tax-296.0M-274.6M-350.6M-251.9M-74.5M-110.9M
Income tax6.23M
Net income-296.0M-274.6M-344.1M-250.0M-80.7M-110.9M
Earnings per share, basic-0.76-0.69-902.26-693.80-0.20-0.28

Balance sheet

LineFY2025FY2024FY2023FY2022FY2020FY2019
Cash and equivalents415.4M569.5M496.6M1.11B78.2M27.8M
Short-term investments73.7M3.03M341.5M473.4K201.1M
Receivables2.31M35.3M2.69M
Inventory212.0K173.0K160.0K277.5K
Current assets500.9M585.3M845.6M1.32B324.6M35.0M
Property, plant and equipment28.8M31.6M
Total assets545.9M629.6M887.1M1.35B344.9M50.1M
Accounts payable104.1M81.2M78.6M81.8M2.17M7.26M
Current liabilities129.5M103.4M102.6M109.9M105.2M12.9M
Total debt1.65M4.37M4.81M3.04M490.7M160.0M
Total liabilities129.5M104.6M103.9M111.0M578.9M200.4M
Shareholders' equity416.4M525.0M783.2M1.24B-233.9M-154.2M
Shares outstanding389.7M396.9M381.4K360.4K396.9M396.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2020FY2019
Cash from operations-253.5M-271.2M-319.3M-241.9M-66.7M-60.8M
Capital spending-164.0K-773.0K-11.8M-2.06M-9.93M-328.6K
Free cash flow-253.7M-272.0M-331.1M-244.0M-76.6M-61.2M
Cash from investing-68.0M348.4M-186.9M27.0M-195.8M35.7M
Cash from financing169.0M-4.87M15.8M240.5M311.5M19.5M
Share buybacks020.0M
Change in cash-154.1M72.9M-487.3M888.6M51.7M27.8M